Nanographene Oxide Attenuates Acute GVHD by Modulating Macrophage Polarization in a Xenogeneic Mouse Model

Abstract Nanographene oxide (NGO) exhibits immunomodulatory activity and holds promise as a therapeutic agent for graft‐versus‐host disease (GVHD). In a xenogeneic GVHD mouse model, NGO administration improves survival and attenuates pathology with reduced weight loss and leukocyte engraftment, with...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Aaron Yu, Hyun Sung Park, Dong‐Hoon Chae, Jae Han Park, Jiyoung Heo, Keonwoo Cho, Jiho Kim, Hyewon Lee, Sueyeon Jee, Chanwoo Kim, Soon Won Choi, Jaechul Ryu, Eun‐Hye Hur, Yunsuk Choi, Eun‐Ji Choi, Mi‐Kyung Oh, Hwa‐Yong Lee, Je‐Hwan Lee, Kyung‐Rok Yu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2025-12-01
Saila:	Advanced Science
Gaiak:	graft versus host disease humanized mouse macrophage nanographene oxide nanomedicine
Sarrera elektronikoa:	https://doi.org/10.1002/advs.202504569
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!